Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Juha Yrjänheikki1, Riitta Keinänen1, M. Pellikka1, Tomas Hökfelt1, Jari Koıstınaho1
1A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland; Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland; and Department of Neuroscience, Karolinska Institute, S-171-77, Stockholm, Sweden

Tóm tắt

Ischemic stroke is the most common life-threatening neurological disease and has limited therapeutic options. One component of ischemic neuronal death is inflammation. Here we show that doxycycline and minocycline, which are broad-spectrum antibiotics and have antiinflammatory effects independent of their antimicrobial activity, protect hippocampal neurons against global ischemia in gerbils. Minocycline increased the survival of CA1 pyramidal neurons from 10.5% to 77% when the treatment was started 12 h before ischemia and to 71% when the treatment was started 30 min after ischemia. The survival with corresponding pre- and posttreatment with doxycycline was 57% and 47%, respectively. Minocycline prevented completely the ischemia-induced activation of microglia and the appearance of NADPH-diaphorase reactive cells, but did not affect induction of glial acidic fibrillary protein, a marker of astrogliosis. Minocycline treatment for 4 days resulted in a 70% reduction in mRNA induction of interleukin-1β-converting enzyme, a caspase that is induced in microglia after ischemia. Likewise, expression of inducible nitric oxide synthase mRNA was attenuated by 30% in minocycline-treated animals. Our results suggest that lipid-soluble tetracyclines, doxycycline and minocycline, inhibit inflammation and are neuroprotective against ischemic stroke, even when administered after the insult. Tetracycline derivatives may have a potential use also as antiischemic compounds in humans.

Từ khóa


Tài liệu tham khảo

10.1016/S0025-7125(16)30039-6

10.1097/00007691-198206000-00001

M A Sande, G L Mandell The Pharmacological Basis of Therapeutics, eds L S Goodman, A Gilman (Macmillan, New York), pp. 1170–1192 (1985).

10.1002/cpt1978234467

10.1128/AAC.8.6.713

A L Aronson J Am Vet Med Assoc 176, 1061–1068 (1980).

10.1177/10454411910020030201

10.1111/j.1749-6632.1994.tb24743.x

10.1016/S0022-5347(17)35268-0

10.1111/j.1749-6632.1994.tb24733.x

10.1111/j.1600-0765.1991.tb01626.x

W Gabler, J Smith, N Tsukuda Res Commun Chem Pathol Pharmacol 8, 151–160 (1992).

10.1073/pnas.93.24.14014

10.1016/S0014-5793(97)00605-4

10.3109/10715769709097783

10.1097/00002281-199803000-00007

10.1007/s002960050030

R A Greenwald, S A Moak, N S Ramamurthy, L M Golub J Rheumatol 19, 927–938 (1992).

P A Wolf, J L Cobb, R B D’Agostino Stroke, Pathophysiology, Diagnosis and Management, eds H J M Barnett, J P Mohr, B M Stein, F M Yatsu (Churchill Livingstone, New York), pp. 3–27 (1997).

Cardiovascular Disease Surveillance: Stroke 1980–1989 (Centers Dis. Control, Atlanta, 1994).

10.1007/BF00227730

10.1136/jnnp.56.1.6

B K Siesjö Brain Energy Metabolism (Wiley, New York, 1978).

G Z Feuerstein, X Wang, F C Barone Cerebrovascular Diseases, eds M D Ginsberg, J Bogousslavsky (Blackwell Scientific, Oxford), pp. 856–862 (1997).

10.1016/S0166-2236(96)10074-6

J Koistinaho, T Hökfelt NeuroReport 8, i–viii (1997).

10.1523/JNEUROSCI.17-23-09157.1997

10.1523/JNEUROSCI.17-08-02746.1997

10.1016/0165-0270(83)90085-7

10.1523/JNEUROSCI.16-13-04146.1996

10.1016/0006-8993(94)90683-1

J R Smith, W L Gabler Res Commun Mol Pathol Pharmacol 88, 303–315 (1995).

10.1007/BF01534560

10.1007/BF02736854

10.1159/000237905

10.1016/0041-008X(67)90034-8

F C Breedveld, D E Trentham Arthritis Rheum 31, R3 (1988).

10.1016/B978-012743170-3.50033-9

10.1016/B978-012743170-3.50034-0

10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F

10.1016/S0301-0082(97)00052-X

10.1126/science.1373520

10.1038/356768a0

10.1182/blood.V77.8.1627.1627

10.1016/0002-9343(90)90181-C

10.1172/JCI115140

10.1073/pnas.94.5.2007

10.1016/0361-9230(92)90033-T